{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T13:04:44Z","timestamp":1772111084678,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.jinf.2008.01.014","type":"journal-article","created":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T12:39:26Z","timestamp":1205325566000},"page":"55-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["suPAR associates to glucose metabolic aberration during glucose stimulation in HIV-infected patients on HAART"],"prefix":"10.1016","volume":"57","author":[{"given":"Ove","family":"Andersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Eugen-Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian","family":"Kofoed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steen B.","family":"Haugaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2008.01.014_bib1","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2008.01.014_bib2","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1210\/jc.2002-020794","article-title":"Clinical review 153: Lipodystrophy in human immunodeficiency virus- infected patients","volume":"87","author":"Chen","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2008.01.014_bib3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1086\/317541","article-title":"Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy","volume":"32","author":"Hadigan","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2008.01.014_bib4","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.2337\/diabetes.54.12.3474","article-title":"Skeletal muscle insulin signaling defects downstream of phosphatidylinositol 3-kinase at the level of Akt are associated with impaired nonoxidative glucose disposal in HIV lipodystrophy","volume":"54","author":"Haugaard","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jinf.2008.01.014_bib5","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor- associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2008.01.014_bib6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2265.2005.02223.x","article-title":"Beta-cell dysfunction and low insulin clearance in insulin-resistant human immunodeficiency virus (HIV)-infected patients with lipodystrophy","volume":"62","author":"Haugaard","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jinf.2008.01.014_bib7","doi-asserted-by":"crossref","first-page":"E677","DOI":"10.1152\/ajpendo.00009.2004","article-title":"Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of beta-cells","volume":"287","author":"Haugaard","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jinf.2008.01.014_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1468-1293.2006.00364.x","article-title":"Glucose-stimulated prehepatic insulin secretion is associated with circulating alanine, triglyceride, glucagon, lactate and TNF-alpha in patients with HIV-lipodystrophy","volume":"7","author":"Haugaard","year":"2006","journal-title":"HIV Med"},{"key":"10.1016\/j.jinf.2008.01.014_bib9","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.metabol.2007.02.007","article-title":"Impaired proinsulin secretion before and during oral glucose stimulation in HIV-infected patients who display fat redistribution","volume":"56","author":"Haugaard","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.jinf.2008.01.014_bib10","doi-asserted-by":"crossref","first-page":"E261","DOI":"10.1152\/ajpendo.00056.2003","article-title":"Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy","volume":"286","author":"Johnson","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jinf.2008.01.014_bib11","doi-asserted-by":"crossref","first-page":"E1072","DOI":"10.1152\/ajpendo.00206.2003","article-title":"Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels","volume":"285","author":"Lihn","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jinf.2008.01.014_bib12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2362.2005.01547.x","article-title":"Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines","volume":"35","author":"He","year":"2005","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jinf.2008.01.014_bib13","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200002180-00001","article-title":"A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome","volume":"14","author":"Carr","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2008.01.014_bib14","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/00002030-200207050-00005","article-title":"Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors","volume":"16","author":"Moyle","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2008.01.014_bib15","doi-asserted-by":"crossref","first-page":"E332","DOI":"10.1152\/ajpendo.00058.2002","article-title":"Metabolic basis of HIV-lipodystrophy syndrome","volume":"283","author":"Sekhar","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jinf.2008.01.014_bib16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/ajcn\/77.2.490","article-title":"Inhibition of lipolysis improves insulin sensitivity in protease inhibitor-treated HIV-infected men with fat redistribution","volume":"77","author":"Hadigan","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jinf.2008.01.014_bib17","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/archinte.165.10.1179","article-title":"Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study","volume":"165","author":"Brown","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jinf.2008.01.014_bib18","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular disease risk factors in HIV patients\u2013association with antiretroviral therapy. Results from the DAD study","volume":"17","author":"Friis-Moller","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2008.01.014_bib19","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/00002030-200305020-00005","article-title":"Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy","volume":"17","author":"Mallon","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2008.01.014_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jmv.21114","article-title":"Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy","volume":"80","author":"Andersen","year":"2008","journal-title":"J Med Virol"},{"key":"10.1016\/j.jinf.2008.01.014_bib21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/stem.150398","article-title":"Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR","volume":"15","author":"Plesner","year":"1997","journal-title":"Stem Cells"},{"key":"10.1016\/j.jinf.2008.01.014_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0014-5793(00)02312-7","article-title":"Enhanced release of soluble urokinase receptor by endothelial cells in contact with peripheral blood cells","volume":"486","author":"Mustjoki","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jinf.2008.01.014_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00126334-200404010-00002","article-title":"Soluble Urokinase Receptor Levels in Plasma During 5 Years of Highly Active Antiretroviral Therapy in HIV-1-Infected Patients","volume":"35","author":"Ostrowski","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2008.01.014_bib24","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2337\/diabetes.47.11.1757","article-title":"Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance","volume":"47","author":"Fernandez-Real","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.jinf.2008.01.014_bib25","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s00125-005-1764-9","article-title":"An immune origin of type 2 diabetes?","volume":"48","author":"Kolb","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.jinf.2008.01.014_bib26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0169-2607(96)01755-5","article-title":"ISEC: a program to calculate insulin secretion","volume":"50","author":"Hovorka","year":"1996","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.jinf.2008.01.014_bib27","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jinf.2008.01.014_bib28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.jinf.2008.01.014_bib29","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(03)12656-6","article-title":"An objective case definition of lipodystrophy in HIV-infected adults: a case-control study","volume":"361","author":"Carr","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2008.01.014_bib30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1469-0691.2004.00850.x","article-title":"The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality","volume":"10","author":"Wittenhagen","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2008.01.014_bib31","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1182\/blood.V96.13.4091","article-title":"Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection","volume":"96","author":"Sidenius","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jinf.2008.01.014_bib32","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1086\/428854","article-title":"Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome","volume":"191","author":"Ostrowski","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2008.01.014_bib33","first-page":"7126","article-title":"Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy","volume":"60","author":"Mustjoki","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.jinf.2008.01.014_bib34","first-page":"1843","article-title":"The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients","volume":"58","author":"Sier","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.jinf.2008.01.014_bib35","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction","volume":"356","author":"Friis-Moller","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2008.01.014_bib36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults","volume":"352","author":"Grinspoon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2008.01.014_bib37","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1468-1293.2006.00362.x","article-title":"The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study","volume":"7","author":"Law","year":"2006","journal-title":"HIV Med"},{"key":"10.1016\/j.jinf.2008.01.014_bib38","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1161\/01.CIR.92.6.1422","article-title":"Insulin, intact and split proinsulin, and coronary artery disease in young men","volume":"92","author":"Bavenholm","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jinf.2008.01.014_bib39","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.jacc.2007.01.088","article-title":"Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study","volume":"49","author":"Jeppesen","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jinf.2008.01.014_bib40","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2337\/dc06-1457","article-title":"Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the Atherosclerosis Risk in Communities Study","volume":"30","author":"Pankow","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jinf.2008.01.014_bib41","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1161\/01.CIR.0000015855.04844.E7","article-title":"Proinsulin is an independent predictor of coronary heart disease: Report from a 27-year follow-up study","volume":"105","author":"Zethelius","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jinf.2008.01.014_bib42","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.metabol.2005.08.018","article-title":"Tumor necrosis factor alpha is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy","volume":"55","author":"Haugaard","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.jinf.2008.01.014_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1530\/eje.1.01835","article-title":"Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic beta-cells","volume":"152","author":"Haugaard","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jinf.2008.01.014_bib44","first-page":"717","article-title":"Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance","volume":"79","author":"Sier","year":"1999","journal-title":"Lab Invest"},{"key":"10.1016\/j.jinf.2008.01.014_bib45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/cyto.1997.0289","article-title":"Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications","volume":"10","author":"Petrovsky","year":"1998","journal-title":"Cytokine"},{"key":"10.1016\/j.jinf.2008.01.014_bib46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000084844","article-title":"IL-6 and its circadian secretion in humans","volume":"12","author":"Vgontzas","year":"2005","journal-title":"Neuroimmunomodulation"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445308000339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445308000339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:32:37Z","timestamp":1758987157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445308000339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0163445308000339"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2008.01.014","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"suPAR associates to glucose metabolic aberration during glucose stimulation in HIV-infected patients on HAART","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2008.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}